KOD KODIAK SCIENCES
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · estimated
What 9 analyst firms say about KODIAK SCIENCES: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
8 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8033
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8048
Recent analyst activity · last 90 days
Our tracked history has 11 reports on KOD from 6 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 left it unchanged and 3 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: HC Wainwright raised its target from $96.00 (set 28 Sep 2026) to $126.00 on 12 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Chardan Capital Markets | Daniil Gataulin | Buy | 11 May 2026 | 61.00 USD |
| Goldman Sachs | Andrea Newkirk | Hold | 30 Sep 2026 | 103.00 USD |
| H.C. Wainwright | Matthew Caufield | Buy | 12 Oct 2026 | 126.00 USD |
| Jefferies | Maury Raycroft | Buy | 28 Sep 2026 | 112.00 USD |
| JPMorgan | Anupam Rama | Buy | 3 Aug 2026 | 66.00 USD |
| Lifesci Capital | Patrick Dolezal | Buy | 28 Sep 2026 | 145.00 USD |
| UBS | Michael Yee | Buy | 28 Sep 2026 | 120.00 USD |
| Weiss Ratings | Unnamed analyst | — | 6 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 22 May 2026 | 96.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:43 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.